Test Price
2,800 AED✅ Home Collection Available
MYH8 Gene Test for Distal Arthrogryposis Type 7 – Genetic Diagnosis in UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited Next‑Generation Sequencing (NGS) processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM across the UAE.
Clinical Guidance: Complimentary telephonic post‑test clinical interpretation by our DHA‑licensed genetic counselling team.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MYH8 gene test detects pathogenic variants linked to distal arthrogryposis type 7, a rare congenital syndrome causing joint contractures and skin webbing. This NGS‑based analysis provides comprehensive sequencing of the MYH8 gene, aiding accurate diagnosis, family planning, and personalised management for UAE patients.
| Feature | Our Test (MYH8 NGS) | Closest Alternative |
|---|---|---|
| Precision / Methodology | Next‑Generation Sequencing (NGS) – deep coverage, detects SNVs, indels, CNVs | Sanger sequencing – limited to coding regions, lower resolution for mosaicism / deep‑intronic variants |
| Diagnostic Sensitivity | 99.9% for MYH8 pathogenic variants (verified on reference datasets) | ~95–98% depending on targeted exons |
| Turnaround Time | 3 to 4 weeks guaranteed | 4 to 8 weeks (often requires reflex testing) |
| Regulatory Compliance | UAE PDPL, Federal Law No. 2 of 2019, ISO 9001:2015 | Varies; often lacks local accreditation |
Physician Insight & Safety Protocols
"As a consultant in medical genetics, I have encountered many families seeking answers for rare congenital conditions. The MYH8 NGS test provides a definitive molecular diagnosis that can guide surgical planning, physiotherapy, and genetic counseling. It is essential that results are interpreted alongside a thorough clinical evaluation and three‑generation family history. I strongly advise pre‑ and post‑test counseling to ensure patients and families fully understand the implications."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication & Clinical Advisory
Do not discontinue or alter any prescribed medication, including analgesics, muscle relaxants, or immunosuppressants, without prior consultation with your treating physician. The genetic test result should not be used as a sole basis for medication changes.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide valid informed consent; known bleeding diathesis that contraindicates venipuncture; unresolved acute skin infection at phlebotomy site.
- Exclusion: Unstable cardiovascular or respiratory condition requiring continuous monitoring – home collection will be deferred until medical clearance.
- Red Flag: Sudden new‑onset joint dislocation with neurovascular compromise, severe respiratory distress, or signs of malignant hyperthermia – seek emergency medical care immediately (call 998 in the UAE).
Patient FAQ & Clinical Guidance
1. What is the purpose of the MYH8 gene test?
The MYH8 NGS identifies pathogenic variants in the MYH8 gene to confirm distal arthrogryposis type 7 diagnosis and guide family planning. It provides a comprehensive analysis of the entire coding region and splice sites, enabling differentiation from phenotypically similar disorders such as Freeman‑Sheldon syndrome. The result assists orthopaedic surgeons and dermatologists in anticipatory management of contractures and skin involvement.
2. How is the sample collected and is home collection available in the UAE?
We offer VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection daily from 8 AM to 11 PM across the UAE. A trained DHA‑licensed phlebotomist visits your location to collect a whole blood or FTA card sample using ISO‑certified cold‑chain processes. Alternatively, you may provide an extracted DNA sample if already available. All collection kits maintain temperature stability from draw to laboratory intake, ensuring sample integrity.
3. How long do results take and who will interpret them?
Results are typically delivered within 3 to 4 weeks via a secure online portal, followed by a telephonic consultation with our clinical geneticist. The final report includes variant classification according to ACMG guidelines, a clinical interpretation summary, and actionable recommendations. Emergency preliminary findings may be expedited upon request for critical medical decisions.
UAE Regulatory & Data Privacy Adherence
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – Patient genomic data processed within UAE sovereign cloud infrastructure, anonymised for secondary analytics.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – Ensures secure electronic health records and telemedicine practices.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – Governs informed consent and clinical safety requirements for genetic testing.
- ISO 9001:2015 Certification (Cert: INT/EGQ/2509DA/3139) – Quality management from sample accession to report release.
Clinical & Logistical Metadata
| Test Name | MYH8 Gene Test for Distal Arthrogryposis Type 7 – NGS |
| Price (AED) | 2800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Whole Blood or FTA Card Sample |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Sequencing |
| ICD-10-CM Code | Q74.3 |
| LOINC Code | 91890-3 |
| DHA Facility License & Laboratory Address | DHA License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians